Conduit Pharmaceuticals Inc. Defensive Interval Ratio

Latest as of June 2026: 299 days

Conduit Pharmaceuticals Inc. defensive interval ratio. Conduit Pharmaceuticals Inc. (CDT) has a Defensive Interval Ratio of 299 days as of June 2026. Defensive assets of $534.16 Million (cash $-, short-term investments $-, receivables $534.16 Million) cover 299 days of daily cash needs of $1.79 Million/day. See working capital position of Conduit Pharmaceuticals Inc. to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

299 days
Days of operational coverage

Defensive Assets

$534.16 Million
Cash + ST Investments + Receivables

Daily Cash Need

$1.79 Million
Current Liabilities ÷ 365

Current Liabilities

$652.79 Million
USD

Defensive Interval Ratio of Conduit Pharmaceuticals Inc. (2024–2025)

Defensive interval ratio of Conduit Pharmaceuticals Inc. from 2024 to 2025. This chart shows how Conduit Pharmaceuticals Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 299 days, meaning defensive assets of $534.16 Million can fund 299 days of operations without new revenue. Check Conduit Pharmaceuticals Inc. asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Conduit Pharmaceuticals Inc. Defensive Interval Ratio by Year (2024–2025)

Conduit Pharmaceuticals Inc. defensive interval ratio by year from 2024 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Conduit Pharmaceuticals Inc. from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see CDT total asset value.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 242 days $462.85 Million $1.91 Million/day $- $- ▼ -12339 days
2024 12581 days $370.24 Million $29.43K/day $- $369.75 Million —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)